|
1
|
Ungaro R, Mehandru S, Allen PB,
Peyrin-Biroulet L and Colombel JF: Ulcerative colitis. Lancet.
389:1756–1770. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
da Silva BC, Lyra AC, Rocha R and Santana
GO: Epidemiology, demographic characteristics and prognostic
predictors of ulcerative colitis. World J Gastroenterol.
20:9458–9467. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Adams SM and Bornemann PH: Ulcerative
colitis. Am Fam Physician. 87:699–705. 2013.PubMed/NCBI
|
|
4
|
Di Sabatino A, Biancheri P, Rovedatti L,
Macdonald TT and Corazza GR: Recent advances in understanding
ulcerative colitis. Intern Emerg Med. 7:103–111. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Maul J and Zeitz M: Ulcerative colitis:
Immune function, tissue fibrosis and current therapeutic
considerations. Langenbecks Arch Surg. 397:1–10. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rieder F and Fiocchi C: Intestinal
fibrosis in inflammatory bowel disease - Current knowledge and
future perspectives. J Crohn's Colitis. 2:279–290. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Manetti M, Rosa I, Messerini L and
Ibba-Manneschi L: Telocytes are reduced during fibrotic remodelling
of the colonic wall in ulcerative colitis. J Cell Mol Med.
19:62–73. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chassaing B and Darfeuille-Michaud A: The
commensal microbiota and enteropathogens in the pathogenesis of
inflammatory bowel diseases. Gastroenterology. 140:1720–1728.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rijnierse A, Nijkamp FP and Kraneveld AD:
Mast cells and nerves tickle in the tummy: Implications for
inflammatory bowel disease and irritable bowel syndrome. Pharmacol
Ther. 116:207–235. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Randhawa PK, Singh K, Singh N and Jaggi
AS: A review on chemical-induced inflammatory bowel disease models
in rodents. Korean J Physiol Pharmacol. 18:279–288. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Whittem CG, Williams AD and Williams CS:
Murine Colitis modeling using Dextran Sulfate Sodium (DSS). J Vis
Exp. 35(1652)2010.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Okayasu I, Hatakeyama S, Yamada M, Ohkusa
T, Inagaki Y and Nakaya R: A novel method in the induction of
reliable experimental acute and chronic ulcerative colitis in mice.
Gastroenterology. 98:694–702. 1990.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chassaing B, Aitken JD, Malleshappa M and
Vijay-Kumar M: Dextran sulfate sodium (DSS)-induced colitis in
mice. Curr Protoc Immunol 104. Unit. 15(25)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alleva E and Santucci D: Guide for the
care and use of laboratory animals. Ethology. 103:1072–1073.
1997.
|
|
15
|
Li YY, Yuece B, Cao HM, Lin HX, Lv S, Chen
JC, Ochs S, Sibaev A, Deindl E, Schaefer C, et al: Inhibition of
p38/Mk2 signaling pathway improves the anti-inflammatory effect of
WIN55 on mouse experimental colitis. Lab Invest. 93:322–333.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kimball ES, Wallace NH, Schneider CR,
D'Andrea MR and Hornby PJ: Vanilloid receptor 1 antagonists
attenuate disease severity in dextran sulphate sodium-induced
colitis in mice. Neurogastroenterol Motil. 16:811–818.
2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Engel MA, Kellermann CA, Rau T, Burnat G,
Hahn EG and Konturek PC: Ulcerative colitis in AKR mice is
attenuated by intraperitoneally administered anandamide. J Physiol
Pharmacol. 59:673–689. 2008.PubMed/NCBI
|
|
18
|
Ippolito C, Colucci R, Segnani C, Errede
M, Girolamo F, Virgintino D, Dolfi A, Tirotta E, Buccianti P, Di
Candio G, et al: Fibrotic and Vascular Remodelling of Colonic Wall
in Patients with Active Ulcerative Colitis. J Crohn's Colitis.
10:1194–1204. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lai S, Yu W, Wallace L and Sigalet D:
Intestinal muscularis propria increases in thickness with corrected
gestational age and is focally attenuated in patients with isolated
intestinal perforations. J Pediatr Surg. 49:114–119.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Melgar S, Karlsson A and Michaëlsson E:
Acute colitis induced by dextran sulfate sodium progresses to
chronicity in C57BL/6 but not in BALB/c mice: Correlation between
symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol.
288:G1328–G1338. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rath HC, Schultz M, Freitag R, Dieleman
LA, Li F, Linde HJ, Schölmerich J and Sartor RB: Different subsets
of enteric bacteria induce and perpetuate experimental colitis in
rats and mice. Infect Immun. 69:2277–2285. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Baumgart DC and Sandborn WJ: Inflammatory
bowel disease: Clinical aspects and established and evolving
therapies. Lancet. 369:1641–1657. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Perše M and Cerar A: Dextran sodium
sulphate colitis mouse model: Traps and tricks. J Biomed
Biotechnol. 2012(718617)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Taghipour N, Molaei M, Mosaffa N,
Rostami-Nejad M, Asadzadeh Aghdaei H, Anissian A, Azimzadeh P and
Zali MR: An experimental model of colitis induced by dextran
sulfate sodium from acute progresses to chronicity in C57BL/6:
Correlation between conditions of mice and the environment.
Gastroenterol Hepatol Bed Bench. 9:45–52. 2016.PubMed/NCBI
|
|
25
|
Tanaka M, Riddell RH, Saito H, Soma Y,
Hidaka H and Kudo H: Morphologic criteria applicable to biopsy
specimens for effective distinction of inflammatory bowel disease
from other forms of colitis and of Crohn's disease from ulcerative
colitis. Scand J Gastroenterol. 34:55–67. 1999.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Geboes K and Dalle I: Influence of
treatment on morphological features of mucosal inflammation. Gut.
50 (Suppl 3):III37–III42. 2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Allison MC, Hamilton-Dutoit SJ, Dhillon AP
and Pounder RE: The value of rectal biopsy in distinguishing
self-limited colitis from early inflammatory bowel disease. Q J
Med. 65:985–995. 1987.PubMed/NCBI
|
|
28
|
Theodossi A, Spiegelhalter DJ, Jass J,
Firth J, Dixon M, Leader M, Levison DA, Lindley R, Filipe I and
Price A: Observer variation and discriminatory value of biopsy
features in inflammatory bowel disease. Gut. 35:961–968.
1994.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Matthes H, Herbst H, Schuppan D, Stallmach
A, Milani S, Stein H and Riecken EO: Cellular localization of
procollagen gene transcripts in inflammatory bowel diseases.
Gastroenterology. 102:431–442. 1992.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rumessen JJ: Ultrastructure of
interstitial cells of Cajal at the colonic submuscular border in
patients with ulcerative colitis. Gastroenterology. 111:1447–1455.
1996.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fratila OC and Craciun C: Ultrastructural
evidence of mucosal healing after infliximab in patients with
ulcerative colitis. J Gastrointestin Liver Dis. 19:147–153.
2010.PubMed/NCBI
|
|
32
|
Gong X, Xu X, Lin S, Cheng Y, Tong J and
Li Y: Alterations in biomechanical properties and microstructure of
colon wall in early-stage experimental colitis. Exp Ther Med.
14:995–1000. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Alex P, Zachos NC, Nguyen T, Gonzales L,
Chen TE, Conklin LS, Centola M and Li X: Distinct cytokine patterns
identified from multiplex profiles of murine DSS and TNBS-induced
colitis. Inflamm Bowel Dis. 15:341–352. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wirtz S, Popp V, Kindermann M, Gerlach K,
Weigmann B, Fichtner-Feigl S and Neurath MF: Chemically induced
mouse models of acute and chronic intestinal inflammation. Nat
Protoc. 12:1295–1309. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Goyal N, Rana A, Ahlawat A, Bijjem KR and
Kumar P: Animal models of inflammatory bowel disease: A review.
Inflammopharmacology. 22:219–233. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sartor RB: Review article: How relevant to
human inflammatory bowel disease are current animal models of
intestinal inflammation? Aliment Pharmacol Ther. 11 (Suppl
3):89–96; discussion 96-97. 1997.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Farkas S, Herfarth H, Rössle M, Schroeder
J, Steinbauer M, Guba M, Beham A, Schölmerich J, Jauch KW and
Anthuber M: Quantification of mucosal leucocyte endothelial cell
interaction by in vivo fluorescence microscopy in
experimental colitis in mice. Clin Exp Immunol. 126:250–258.
2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mizoguchi E, Low D, Ezaki Y and Okada T:
Recent updates on the basic mechanisms and pathogenesis of
inflammatory bowel diseases in experimental animal models. Intest
Res. 18:151–167. 2020.PubMed/NCBI View Article : Google Scholar
|
